Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel k-Opioid Receptor Selective Partial Agonist

被引:20
|
作者
De Marco, Rossella [1 ]
Bedini, Andrea [2 ]
Spampinato, Santi [2 ]
Comellini, Lorenzo [1 ]
Zhao, Junwei [1 ]
Artali, Roberto [3 ]
Gentilucci, Luca [1 ]
机构
[1] Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy
[2] Univ Bologna, Dept Pharm & Biotechnol, Via Irnerio 48, I-40126 Bologna, Italy
[3] Scientia Advice, I-20832 Monza, Italy
关键词
ENZYMATIC-HYDROLYSIS; PROLINE SURROGATES; ANALOGS; PEPTIDE; POTENT; LIGANDS; STABILITY; AFFINITY; DESIGN; SYSTEM;
D O I
10.1021/acs.jmedchem.8b00296
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein we present the expedient synthesis of endomorphin-1 analogues containing stereoisomeric beta(2)-homo-Freidinger lactam-like scaffolds ([Amo(2)]EM), and we discuss opioid receptor (OR) affinity, enzymatic stability, functional activity, in vivo antinociceptive effects, and conformational and molecular docking analysis. Hence, H-Tyr-Amo-Trp-PheNH(2) resulted to be a new chemotype of highly stable, selective, partial KOR agonist inducing analgesia, therefore displaying great potential interest as a painkiller possibly with reduced harmful side effects.
引用
收藏
页码:5751 / 5757
页数:7
相关论文
共 38 条
  • [1] Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor
    Hosohata, K
    Burkey, TH
    Alfaro-Lopez, J
    Varga, E
    Hruby, VJ
    Roeske, WR
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) : 111 - 114
  • [2] Endomorphin-1, an endogenous μ-opioid receptor-selective agonist, stimulates oxygen consumption in mice
    Asakawa, A
    Inui, A
    Ueno, N
    Fujimiya, M
    Fujino, MA
    Kasuga, M
    HORMONE AND METABOLIC RESEARCH, 2000, 32 (02) : 51 - 52
  • [3] Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor.
    Hosohata, K
    Burkey, TH
    Alfaro-Lopez, J
    Varga, E
    Hruby, VJ
    Roeske, WR
    Yamamura, HI
    FASEB JOURNAL, 1998, 12 (04): : A152 - A152
  • [4] Endomorphin-1 and endomorphin-2:: pharmacology of the selective endogenous μ-opioid receptor agonists
    Horvath, G
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) : 437 - 463
  • [5] Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro
    Gorbunov, A. S.
    Mukhomedzyanov, A. V.
    Popov, S. V.
    Azev, V. N.
    Maslov, L. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, : 86 - 90
  • [6] Identification of Endomorphin-1 and Endomorphin-2 Binding Sites in Human μ-Opioid Receptor by Antisense Oligonucleotide Strategy
    Fichna, Jakub
    Gach, Katarzyna
    Perlikowska, Renata
    Poels, Jeroen
    Broeck, Jozef Vanden
    Szemraj, Janusz
    Janecka, Anna
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (06) : 507 - 512
  • [7] Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds
    White, Kate L.
    Scopton, Alex P.
    Rives, Marie-Laure
    Bikbulatov, Ruslan V.
    Polepally, Prabhakar R.
    Brown, Peter J.
    Kenakin, Terrance
    Javitch, Jonathan A.
    Zjawiony, Jordan K.
    Roth, Bryan L.
    MOLECULAR PHARMACOLOGY, 2014, 85 (01) : 83 - 90
  • [8] Endomorphin-1, an endogenous μ-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice
    Ukai, M
    Okuda, A
    PEPTIDES, 2003, 24 (05) : 741 - 744
  • [9] Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1
    Jinsmaa, Yunden
    Marczak, Ewa
    Fujita, Yoshio
    Shiotani, Kirnitaka
    Miyazaki, Anna
    Li, Tingyou
    Tsuda, Yuko
    Arnbo, Akihiro
    Sasaki, Yusuke
    Bryant, Sharon D.
    Okada, Yoshio
    Lazarus, Lawrence H.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 84 (02) : 252 - 258
  • [10] The μ-opioid receptor agonist endomorphin-1 causes a panicolytic-like effect in a prey versus predator paradigm
    Coelho Silva, Weverton Castro
    de Sousa, Guilherme Bazaglia
    Sgobbi, Renata Ferreira
    Coimbra, Norberto Cysne
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1084 - 1085